Author Schuster, Volker
-
2012 | Conference Abstract
WHEN SHOULD THE FAS GENE BE SEQUENCED IN PATIENTS WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY
Rensing-Ehl, A.; Janda, A.; Vach, W.; Gladstone, B. P.; Abinun, M.; Albert, M. H. & Butler, K. et al. (2012)
Journal of Clinical Immunology, 32 pp. 73-74. 15th Biennial Meeting European-Society-for-Immunodeficiency (ESID), Florence, ITALY.
New york: Springer.
Details WoS
-
2013 | Journal Article |
Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia
Rensing-Ehl, A.; Janda, A.; Lorenz, M. R.; Gladstone, B. P.; Fuchs, I.; Abinun, M. & Albert, M. et al. (2013)
Haematologica, 98(12) pp. 1948-1955. DOI: https://doi.org/10.3324/haematol.2012.081901
Details DOI PMID PMC WoS
-
2014 | Journal Article | Letter Note
Report of the Third European Expert Meeting on Rotavirus Vaccination: Progress in rotavirus universal mass vaccination in Europe
Huppertz, H.-I.; Borte, M.; Schuster, V.; Giaquinto, C. & Vesikari, T. (2014)
Vaccine, 32(34) pp. 4243-4248. DOI: https://doi.org/10.1016/j.vaccine.2014.05.029
Details DOI PMID PMC WoS
-
2015 | Conference Abstract
Hyperactive mTOR Pathway Promotes Lymphoproliferation and Abnormal Differentiation in Human Autoimmune Lymphoproliferative Syndrome
Voelkl, S.; Rensing-Ehl, A.; Allgaeuer, A.; Schreiner, E.; Lorenz, M. R.; Rohr, J. & Klemann, C. et al. (2015)
Blood, 126(23) 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL.
Washington: Amer Soc Hematology.
Details WoS
-
2016 | Journal Article
Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome
Voelkl, S.; Rensing-Ehl, A.; Allgaeuer, A.; Schreiner, E.; Lorenz, M. R.; Rohr, J. & Klemann, C. et al. (2016)
Blood, 128(2) pp. 227-238. DOI: https://doi.org/10.1182/blood-2015-11-685024
Details DOI PMID PMC WoS
-
2020 | Journal Article |
Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groups
Assmann, G.; Köhm, M.; Schuster, V.; Behrens, F.; Mössner, R. ; Magnolo, N. & Oji, V. et al. (2020)
BMC Medical Genetics, 21(1). DOI: https://doi.org/10.1186/s12881-020-01037-7
Details DOI